List of Tables
Table 1. Global Primary Biliary Cirrhosis Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Primary Biliary Cirrhosis Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Primary Biliary Cirrhosis Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Primary Biliary Cirrhosis Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Primary Biliary Cirrhosis Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Primary Biliary Cirrhosis Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Primary Biliary Cirrhosis Drug, Product Type & Application
Table 12. Global Key Manufacturers of Primary Biliary Cirrhosis Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Primary Biliary Cirrhosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Biliary Cirrhosis Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Biliary Cirrhosis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Primary Biliary Cirrhosis Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2020-2025)
Table 19. Global Primary Biliary Cirrhosis Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2026-2031)
Table 21. Global Primary Biliary Cirrhosis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Primary Biliary Cirrhosis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Primary Biliary Cirrhosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Primary Biliary Cirrhosis Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Primary Biliary Cirrhosis Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Primary Biliary Cirrhosis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Primary Biliary Cirrhosis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Primary Biliary Cirrhosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Primary Biliary Cirrhosis Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Primary Biliary Cirrhosis Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Primary Biliary Cirrhosis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Primary Biliary Cirrhosis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Primary Biliary Cirrhosis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Biliary Cirrhosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Primary Biliary Cirrhosis Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Primary Biliary Cirrhosis Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Primary Biliary Cirrhosis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Primary Biliary Cirrhosis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Primary Biliary Cirrhosis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2020-2025)
Table 53. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2026-2031)
Table 54. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2020-2025)
Table 63. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2026-2031)
Table 64. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. AlbireoPharma Company Information
Table 71. AlbireoPharma Description and Business Overview
Table 72. AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. AlbireoPharma Primary Biliary Cirrhosis Drug Product
Table 74. AlbireoPharma Recent Developments/Updates
Table 75. CymaBay Therapeutics, Inc. Company Information
Table 76. CymaBay Therapeutics, Inc. Description and Business Overview
Table 77. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product
Table 79. CymaBay Therapeutics, Inc. Recent Developments/Updates
Table 80. Dr. Falk Pharma GmbH Company Information
Table 81. Dr. Falk Pharma GmbH Description and Business Overview
Table 82. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product
Table 84. Dr. Falk Pharma GmbH Recent Developments/Updates
Table 85. Enanta Pharmaceuticals, Inc. Company Information
Table 86. Enanta Pharmaceuticals, Inc. Description and Business Overview
Table 87. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 89. Enanta Pharmaceuticals, Inc. Recent Developments/Updates
Table 90. GlaxoSmithKline Plc Company Information
Table 91. GlaxoSmithKline Plc Description and Business Overview
Table 92. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product
Table 94. GlaxoSmithKline Plc Recent Developments/Updates
Table 95. Intercept Pharmaceuticals, Inc. Company Information
Table 96. Intercept Pharmaceuticals, Inc. Description and Business Overview
Table 97. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 99. Intercept Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Primary Biliary Cirrhosis Drug Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. MediGene AG Company Information
Table 106. MediGene AG Description and Business Overview
Table 107. MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. MediGene AG Primary Biliary Cirrhosis Drug Product
Table 109. MediGene AG Recent Developments/Updates
Table 110. NGM Biopharmaceuticals, Inc. Company Information
Table 111. NGM Biopharmaceuticals, Inc. Description and Business Overview
Table 112. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 114. NGM Biopharmaceuticals, Inc. Recent Developments/Updates
Table 115. Virobay Inc. Company Information
Table 116. Virobay Inc. Description and Business Overview
Table 117. Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Virobay Inc. Primary Biliary Cirrhosis Drug Product
Table 119. Virobay Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Primary Biliary Cirrhosis Drug Distributors List
Table 123. Primary Biliary Cirrhosis Drug Customers List
Table 124. Primary Biliary Cirrhosis Drug Market Trends
Table 125. Primary Biliary Cirrhosis Drug Market Drivers
Table 126. Primary Biliary Cirrhosis Drug Market Challenges
Table 127. Primary Biliary Cirrhosis Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Primary Biliary Cirrhosis Drug
Figure 2. Global Primary Biliary Cirrhosis Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Biliary Cirrhosis Drug Market Share by Type: 2024 & 2031
Figure 4. Budesonide Product Picture
Figure 5. FFP-104 Product Picture
Figure 6. GSK-2330672 Product Picture
Figure 7. MBX-8025 Product Picture
Figure 8. NGM-282 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Primary Biliary Cirrhosis Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Primary Biliary Cirrhosis Drug Market Share by Application: 2024 & 2031
Figure 12. Clinic
Figure 13. Hospital
Figure 14. Others
Figure 15. Global Primary Biliary Cirrhosis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Primary Biliary Cirrhosis Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Primary Biliary Cirrhosis Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Primary Biliary Cirrhosis Drug Report Years Considered
Figure 20. Primary Biliary Cirrhosis Drug Sales Share by Manufacturers in 2024
Figure 21. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Primary Biliary Cirrhosis Drug Players: Market Share by Revenue in Primary Biliary Cirrhosis Drug in 2024
Figure 23. Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Primary Biliary Cirrhosis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Primary Biliary Cirrhosis Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Primary Biliary Cirrhosis Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Primary Biliary Cirrhosis Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Primary Biliary Cirrhosis Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Primary Biliary Cirrhosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Primary Biliary Cirrhosis Drug by Type (2020-2031)
Figure 60. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Primary Biliary Cirrhosis Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Primary Biliary Cirrhosis Drug by Application (2020-2031)
Figure 63. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Primary Biliary Cirrhosis Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
